Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.

PMID: 31516692
Journal: Clinical and Translational Allergy
Year: 2019
Reference: Clin Transl Allergy. 2019 Sep 9;9:44. doi: 10.1186/s13601-019-0279-2. eCollection 2019.
Impact factor:
Publication type: Review in international publication
Authors: Aberer, W; Agache, I; Agache, Ioana; Akdis, C A; Akdis, Cezmi A; Akdis, M; Aliberti, M R; Almeida, R; Amat, F; Angles, R et al.
DOI: 10.1186/s13601-019-0279-2

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1).

PMID: 31559071
Journal: Journal of Thoracic Disease
Year: 2019
Reference: J Thorac Dis. 2019 Aug;11(8):3633-3642. doi: 10.21037/jtd.2019.08.64.
Impact factor: 2.027
Publication type: Paper in international publication
Authors: Tsiligianni, Ioanna, Bousquet, Jean, Pham-Thi, Nhan, Bedbrook, Anna, Agache, Ioana, Annesi-Maesano, Isabella, Ansotegui, Ignacio, Anto, Josep M, Bachert, Claus, Benveniste, Samuel et al.
DOI: 10.21037/jtd.2019.08.64

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2).

PMID: 31656683
Journal: Journal of Thoracic Disease
Year: 2019
Reference: J Thorac Dis. 2019 Sep;11(9):4072-4084. doi: 10.21037/jtd.2019.09.38.
Impact factor: 2.027
Publication type: Review in international publication
Authors: Williams, Sian, Pham-Thi, Nhan, Bedbrook, Anna, Agache, Ioana, Annesi-Maesano, Isabella, Ansotegui, Ignacio, Anto, Josep M, Bachert, Claus, Benveniste, Samuel, Bewick, Mike et al.
DOI: 10.21037/jtd.2019.09.38

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1).

PMID: 31559071
Journal: Journal of Thoracic Disease
Year: 2019
Reference: J Thorac Dis. 2019 Aug;11(8):3633-3642. doi: 10.21037/jtd.2019.08.64.
Impact factor:
Publication type: Paper in international publication
Authors: Agache, Ioana; Annesi-Maesano, Isabella; Ansotegui, Ignacio; Anto, Josep M; Bachert, Claus; Bedbrook, Anna; Benveniste, Samuel; Bewick, Mike; Billo, Nils; Bosnic-Anticevich, Sinthia et al.
DOI: 10.21037/jtd.2019.08.64

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2).

PMID: 31656683
Journal: Journal of Thoracic Disease
Year: 2019
Reference: J Thorac Dis. 2019 Sep;11(9):4072-4084. doi: 10.21037/jtd.2019.09.38.
Impact factor:
Publication type: Review in international publication
Authors: Agache, Ioana; Annesi-Maesano, Isabella; Ansotegui, Ignacio; Anto, Josep M; Bachert, Claus; Bedbrook, Anna; Benveniste, Samuel; Bewick, Mike; Billo, Nils; Bosnic-Anticevich, Sinthia et al.
DOI: 10.21037/jtd.2019.09.38

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial.

PMID: 31103412
Journal: Lancet Respiratory Medicine
Year: 2019
Reference: Lancet Respir Med. 2019 Jul;7(7):569-580. doi: 10.1016/S2213-2600(19)30139-0. Epub 2019 May 15.
Impact factor: 22.992
Publication type: Paper in international publication
Authors: Nowak, Anna K, Scagliotti, Giorgio V, Gaafar, Rabab, Popat, Sanjay, Vogelzang, Nicholas J, Grosso, Federica, Aboelhassan, Rasha, Jakopovic, Marko, Ceresoli, Giovanni L, Taylor, Paul et al.
DOI: 10.1016/S2213-2600(19)30139-0

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial.

PMID: 31103412
Journal: Lancet Respiratory Medicine
Year: 2019
Reference: Lancet Respir Med. 2019 Jul;7(7):569-580. doi: 10.1016/S2213-2600(19)30139-0. Epub 2019 May 15.
Impact factor:
Publication type: Paper in international publication
Authors: Aboelhassan, Rasha; Barrueco, Jose; Cedres, Susana; Ceresoli, Giovanni L; Fennell, Dean A; Gaafar, Rabab; Grosso, Federica; Jakopovic, Marko; Kim, Miyoung; Kuribayashi, Kozo et al.
DOI: 10.1016/S2213-2600(19)30139-0

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.

PMID: 31566307
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2019
Reference: N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
Impact factor: 70.67
Publication type: Paper in international publication
Authors: Abe, S, Flaherty, Kevin R, Wells, Athol U, Cottin, Vincent, Devaraj, Anand, Walsh, Simon L F, Inoue, Yoshikazu, Richeldi, Luca, Kolb, Martin, Tetzlaff, Kay et al.
DOI: 10.1056/NEJMoa1908681

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.

PMID: 31566307
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2019
Reference: N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
Impact factor:
Publication type: Paper in international publication
Authors: Abe, S; Aburto, M; Acosta, O; Andrews, C; Antin-Ozerkis, D; Arce, G; Arias, M; Avdeev, S; Barczyk, A; Bascom, R et al.
DOI: 10.1056/NEJMoa1908681

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.

PMID: 31173551
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2019
Reference: J Clin Oncol. 2019 Nov 10;37(32):2968-2973. doi: 10.1200/JCO.18.02238. Epub 2019 Jun 7.
Impact factor: 28.245
Publication type: Paper in international publication
Authors: Del Campo, Josep M, Matulonis, Ursula A, Malander, Susanne, Provencher, Diane, Mahner, Sven, Follana, Philippe, Waters, Justin, Berek, Jonathan S, Woie, Kathrine, Oza, Amit M et al.
DOI: 10.1200/JCO.18.02238

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.

PMID: 31173551
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2019
Reference: J Clin Oncol. 2019 Nov 10;37(32):2968-2973. doi: 10.1200/JCO.18.02238. Epub 2019 Jun 7.
Impact factor:
Publication type: Paper in international publication
Authors: Arora, Sujata; Benigno, Benedict; Berek, Jonathan S; Canzler, Ulrich; Del Campo, Josep M; Follana, Philippe; Gil-Martin, Marta; Gilbert, Lucy; Hazard, Sebastien J; Lesoin, Anne et al.
DOI: 10.1200/JCO.18.02238

Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer.

PMID: 31357748
Journal: Cancers
Year: 2019
Reference: Cancers (Basel). 2019 Jul 28;11(8). pii: cancers11081068. doi: 10.3390/cancers11081068.
Impact factor: 6.162
Publication type: Paper in international publication
Authors: Blanc, Jean-Frederic, Mirakhur, Beloo, Jong, Floris A de, Belanger, Bruce, Bekaii-Saab, Tanios, Siveke, Jens T, Macarulla, Teresa, Chen, Li-Tzong et al.
DOI: 10.3390/cancers11081068

Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer.

PMID: 31357748
Journal: Cancers
Year: 2019
Reference: Cancers (Basel). 2019 Jul 28;11(8). pii: cancers11081068. doi: 10.3390/cancers11081068.
Impact factor:
Publication type: Paper in international publication
Authors: Bekaii-Saab, Tanios; Belanger, Bruce; Blanc, Jean-Frederic; Chen, Li-Tzong; Jong, Floris A de; Macarulla, Teresa; Mirakhur, Beloo; Siveke, Jens T et al.
DOI: 10.3390/cancers11081068

Noncanonical TGFbeta Pathway Relieves the Blockade of IL1beta/TGFbeta-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer.

PMID: 30979739
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 Jul 15;25(14):4466-4479. doi: 10.1158/1078-0432.CCR-18-3957. Epub 2019 Apr 12.
Impact factor:
Publication type: Paper in international publication
Authors: Albert, Nerea; Berdiel-Acer, Mireia; Capella, Gabriel; Cimas, Francisco J; Garcia, Elena; Garcia-Vicien, Gemma; Goncalves-Ribeiro, Samuel; Guillen Diaz-Maroto, Natalia; Mollevi, David G; Moreno, Victor et al.
DOI: 10.1158/1078-0432.CCR-18-3957

Noncontrast Computed Tomography Alberta Stroke Program Early CT Score May Modify Intra-Arterial Treatment Effect in DAWN.

PMID: 31345135
Journal: STROKE
Year: 2019
Reference: Stroke. 2019 Sep;50(9):2404-2412. doi: 10.1161/STROKEAHA.118.024583. Epub 2019 Jul 26.
Impact factor: 6.046
Publication type: Paper in international publication
Authors: Haussen, Diogo C, Bonafe, Alain, Budzik, Ronald J, Yavagal, Dileep R, Hanel, Ricardo A, Hassan, Ameer E, Ribo, Marc, Cognard, Christophe, Sila, Cathy A, Morgan, Patricia M et al.
DOI: 10.1161/STROKEAHA.118.024583

Noncontrast Computed Tomography Alberta Stroke Program Early CT Score May Modify Intra-Arterial Treatment Effect in DAWN.

PMID: 31345135
Journal: STROKE
Year: 2019
Reference: Stroke. 2019 Sep;50(9):2404-2412. doi: 10.1161/STROKEAHA.118.024583. Epub 2019 Jul 26.
Impact factor:
Publication type: Paper in international publication
Authors: Bhuva, Parita; Bonafe, Alain; Budzik, Ronald J; Cognard, Christophe; Hanel, Ricardo A; Hassan, Ameer E; Haussen, Diogo C; Jadhav, Ashutosh P; Jovin, Tudor G; Liebeskind, David S et al.
DOI: 10.1161/STROKEAHA.118.024583

Non-eosinophilic severe exacerbations of COPD: what about antibiotics?

PMID: 31645283
Journal: Lancet Respiratory Medicine
Year: 2019
Reference: Lancet Respir Med. 2019 Nov;7(11):e33. doi: 10.1016/S2213-2600(19)30347-9.
Impact factor: 22.992
Publication type: Letter or abstract
Authors: Miravitlles, Marc, Llor, Carl et al.
DOI: 10.1016/S2213-2600(19)30347-9

Non-eosinophilic severe exacerbations of COPD: what about antibiotics?

PMID: 31645283
Journal: Lancet Respiratory Medicine
Year: 2019
Reference: Lancet Respir Med. 2019 Nov;7(11):e33. doi: 10.1016/S2213-2600(19)30347-9.
Impact factor:
Publication type: Letter or abstract
Authors: Llor, Carl; Miravitlles, Marc et al.
DOI: 10.1016/S2213-2600(19)30347-9

Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis.

PMID: 30621746
Journal: ARTHRITIS RESEARCH & THERAPY
Year: 2019
Reference: Arthritis Res Ther. 2019 Jan 8;21(1):11. doi: 10.1186/s13075-018-1772-z.
Impact factor: 4.148
Publication type: Paper in international publication
Authors: Rodriguez-Lozano, Carlos, Linares, Luis Francisco, Urruticoechea, Ana, Collantes, Eduardo, Morla, Rosa Maria, Reina, Delia, Cuende, Eduardo, Zarco, Pedro, Fernandez-Espartero, Maria Cruz, Garcia-Vicuna, Rosario et al.
DOI: 10.1186/s13075-018-1772-z

Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis.

PMID: 30621746
Journal: ARTHRITIS RESEARCH & THERAPY
Year: 2019
Reference: Arthritis Res Ther. 2019 Jan 8;21(1):11. doi: 10.1186/s13075-018-1772-z.
Impact factor:
Publication type: Paper in international publication
Authors: Albinana, Nestor; Almirall, Miriam; Aparicio, Maria; Ariza, Rafael; Avendano, Cristina; Batlle, Enrique; Calvo, Gonzalo; Campos, Cristina; Clavaguera, Teresa; Collantes, Eduardo et al.
DOI: 10.1186/s13075-018-1772-z

Non-intravenous carbapenem-sparing antibiotics for the definitive treatment of bacteremia due to Enterobacteriaceae-producing ESBL or AmpC beta-lactamase. A propensity score study.

PMID: 31075401
Journal: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Year: 2019
Reference: Int J Antimicrob Agents. 2019 Aug;54(2):189-196. doi: 10.1016/j.ijantimicag.2019.05.004. Epub 2019 May 7.
Impact factor: 4.615
Publication type: Paper in international publication
Authors: Ayestaran, Ana, Morales-Cartagena, Alejandra, Ribera, Alba, Duarte, Alejandra, Abelenda, Gabriela, Rodriguez-Bano, Jesus, Martinez-Montauti, Joaquim, Sierra, Montserrat, Loureiro-Amigo, Jose, Ortega, Lucia et al.
DOI: 10.1016/j.ijantimicag.2019.05.004

Non-intravenous carbapenem-sparing antibiotics for the definitive treatment of bacteremia due to Enterobacteriaceae-producing ESBL or AmpC beta-lactamase. A propensity score study.

PMID: 31075401
Journal: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Year: 2019
Reference: Int J Antimicrob Agents. 2019 Aug;54(2):189-196. doi: 10.1016/j.ijantimicag.2019.05.004. Epub 2019 May 7.
Impact factor:
Publication type: Paper in international publication
Authors: Abelenda, Gabriela; Ayestaran, Ana; Clemente, Mercedes; Duarte, Alejandra; Fernandez-Hidalgo, Nuria; Loureiro-Amigo, Jose; Martinez-Montauti, Joaquim; Meije, Yolanda; Morales-Cartagena, Alejandra; Ortega, Lucia et al.
DOI: 10.1016/j.ijantimicag.2019.05.004

Noninvasive approach for de novo acute hypoxemic respiratory failure: noninvasive ventilation, high-flow nasal cannula, both or none?

PMID: 30516585
Journal: Current Opinion in Critical Care
Year: 2019
Reference: Curr Opin Crit Care. 2019 Feb;25(1):54-62. doi: 10.1097/MCC.0000000000000570.
Impact factor: 2.54
Publication type: Paper in international publication
Authors: Garcia-de-Acilu, Marina, Patel, Bhakti K, Roca, Oriol et al.
DOI: 10.1097/MCC.0000000000000570

Noninvasive approach for de novo acute hypoxemic respiratory failure: noninvasive ventilation, high-flow nasal cannula, both or none?

PMID: 30516585
Journal: Current Opinion in Critical Care
Year: 2019
Reference: Curr Opin Crit Care. 2019 Feb;25(1):54-62. doi: 10.1097/MCC.0000000000000570.
Impact factor:
Publication type: Paper in international publication
Authors: Garcia-de-Acilu, Marina; Patel, Bhakti K; Roca, Oriol et al.
DOI: 10.1097/MCC.0000000000000570